89bio, Inc. (ETNB) — Analyst outlook / Analyst consensus target is. Based on 15 analyst ratings, the consensus is bullish — 9 Buy, 6 Hold.
The consensus price target is $22.00 (low: $12.00, high: $29.00), representing an upside of 48.2% from the current price $14.84.
ETNB Stock — 12-Month Price Forecast
$22.00
▲ +48.25% Upside
Average Price Target
Based on 15 Wall Street analysts offering 12-month price targets for 89bio, Inc., the average price target is $22.00, with a high forecast of $29.00, and a low forecast of $12.00.
The average price target represents a +48.25% change from the last price of $14.84.
Highest Price Target
$29.00
Average Price Target
$22.00
Lowest Price Target
$12.00
ETNB Analyst Ratings
Buy
Based on 15 analysts giving stock ratings to 89bio, Inc. in the past 3 months
